Sivem Pharmaceuticals Ranitidine recall in Canada: impurity risk
In plain language
This recall involves Sivem Pharmaceuticals Ranitidine 150 mg and 300 mg tablets sold in Canada. It's being recalled because affected lots may contain an impurity called N-nitrosodimethylamine (NDMA). Stop using the product and follow the return steps in the official notice.
What to do
- Stop using the product immediately.
- Check the lot numbers on your product.
- Contact your pharmacist or healthcare provider for advice.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Ranitidine 300 mg Tablet
Lot: K50941, K50624, K50947, K50950
Ranitidine 150 mg Tablet
Lot: K46484, K50204, K46485, K50206, K50590, K50677, K50908, K48440, K48679, K50207, K50594, K50925, K50928, K50932, K50935, K51080
Why this matters
Impurity risk
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: K46484, K50204, K46485, K50206, K50590, K50677, K50908, K48440, K48679, K50207, K50594, K50925, K50928, K50932, K50935, K51080, K50941, K50624, K50947, K50950
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Impurity risk
What should consumers do?
Stop using the product immediately. Check the lot numbers on your product. Contact your pharmacist or healthcare provider for advice.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Impurity risk
When was this product recalled?
This product was recalled on October 17, 2019.
Is the Sivem Pharmaceuticals brand affected by this recall?
Yes, Sivem Pharmaceuticals products are affected by this recall. This recall involves Sivem Pharmaceuticals Ranitidine 150 mg and 300 mg tablets sold in Canada. It's being recalled because affected lots may contain an impurity called N-nitrosodimethylamine (NDMA). Stop using the product and follow the return steps in the official notice.